Riskpilot← Back to searchSign inGet full accessVironova Thionation AB
ABBankruptOrg 5568930324Research and experimental development on natural sciences and engineering · NACE 7210Est. 20120 employees
Revenue 2021
SEK 413K
EBITDA margin
-462.5%
-26% vs 2020
Equity ratio
16.1%
Financial strength
Net profit 2021
SEK -1,9M
-24% vs 2020
| Revenue | SEK 413K | — |
| EBITDA | SEK -1,9M | -26% |
| Net profit | SEK -1,9M | -24% |
| Total assets | SEK 1,3M | -33% |
| Equity | SEK 214K | -60% |
| Employees | 0 | — |
Legal name
Vironova Thionation AB
Org number
5568930324
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 maj 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva forskning, utveckling och kommersialiseringverksamhet inom det kemiska området, samt att bedriva därmed förenlig verksamhet.
Address
Email
lisse-lotte.bolin@fylgia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 413 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −283 | −1 005 | −1 990 | −1 514 | −1 910 |
| Depreciation & amort. | −34 | −35 | −37 | −37 | −18 |
| EBIT | −317 | −1 040 | −2 027 | −1 551 | −1 928 |
| Net financials | — | — | — | −2 | — |
| Profit before tax | −317 | −1 040 | −2 027 | −1 553 | −1 928 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −317 | −1 040 | −2 027 | −1 553 | −1 928 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 826 | 1 115 | 2 011 | 1 976 | 1 329 |
| Equity | 257 | 217 | 90 | 537 | 214 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 569 | 898 | 1 921 | 1 439 | 1 115 |
| Total debt | 569 | 898 | 1 921 | 1 439 | 1 115 |
EBITDA margin
-462.5%
This company
15.8%
Market median
-3027% vs market
20172021
Equity ratio
16.1%
This company
38.2%
Market median
-58% vs market
20172021
Return on equity
-900.9%
This company
18.4%
Market median
-4996% vs market
20172021
Net profit margin
-466.8%
This company
8.1%
Market median
-5863% vs market
20172021
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20172021
Debt / equity
5.21×
This company
0.62×
Market median
-740% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JO Chief Auditor | Chief Auditor | 2021 |
LM Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Deputy Board Member | 2021 – 2023 | |
| Deputy Board Member | 2023 – 2024 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
M Homman AB
Vironova Thionation AB Board members of Vironova Thionation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Tilander | Chief Auditor | 0 companies |
| Lisse-Lotte Mariana Teresia Bolin | Liquidator | 0 companies |
| Maria Homman Loudiye | Deputy Board Member | 0 companies |
| Robert Ludvig Alexander Almqvist | Deputy Board Member | 0 companies |
| Mohamed Homman Loudiye | Chairman | 0 companies |
| Jan Olov Einar Bergman | Board of Directors | 0 companies |